Otomagnetics, Inc. is pioneering a novel magnetic injection delivery system designed to non-invasively administer therapeutic agents to hard-to-reach areas of the body, such as the inner and middle ear, as well as the eye. This innovative technology utilizes a proprietary magnetic injector combined with biodegradable magnetic particles, which are composed of FDA-approved materials. The system has shown promise in animal studies for treating various conditions, including hearing loss, tinnitus, and middle ear infections, while also offering potential applications for ocular diseases like macular degeneration and glaucoma. By circumventing traditional delivery methods that often require invasive procedures, Otomagnetics aims to enhance patient care and expand treatment options.

The technology's ability to deliver drugs directly to the cochlea and middle ear without the need for surgery or puncturing the eardrum represents a significant advancement in medical treatment. Additionally, the magnetic delivery system could revolutionize ocular drug administration by eliminating the need for needle injections, thereby reducing patient stress and complications. With its platform technology, Otomagnetics is positioned to address multiple unmet medical needs and has attracted interest from pharmaceutical companies seeking to leverage this innovative approach for their proprietary compounds. Overall, Otomagnetics is set to transform the landscape of drug delivery in both otolaryngology and ophthalmology.

United States

Otomagnetics is a medical device manufacturer that designs and commercializes magnetic injection system for the delivery of drugs to the inner ear.

Otomagnetics, Inc.

Company Details